Drug lookup
Drug reference

biperiden

Tertiary amine, muscarinic antagonist (CNS-acting) · Anticholinergic

Tertiary amine, muscarinic antagonist (CNS-acting)Anticholinergic
CDSCO approved
EXCRETION
not curated
INTERACTIONS
4 major
SEVERE in our sources
PREGNANCY
C
FDA category + note
Top interactions
  • Potassium ChlorideSevereDatabaseDDInter
  • Potassium CitrateSevereDatabaseDDInter
  • TopiramateSevereDatabaseDDInter
  • ZonisamideSevereDatabaseDDInter

Mechanism

Tertiary amine that readily gains access to the CNS. Mainly used to treat tremor.

Indications

Parkinson’s diseaseExtrapyramidal symptoms that commonly occur as side effects of antipsychotic drugsDrug-induced parkinsonismParkinson's disease

Dosing

Adult
2–10 mg/day oral, i.m. or i.v.

Contraindications

  • Not recommended for elderly patients
  • Not recommended for demented patients

Side effects

Common
Antimuscarinic adverse effects similar to atropineCognitive impairmentperipheral antimuscarinic adverse effectsimpairment of memoryorganic confusional statesblurred visionurinary retention
Serious
  • Exacerbation of tardive dyskinesia
  • cholinergic rebound following abrupt anticholinergic withdrawal

Pregnancy & lactation

Pregnancy

C

Lactation

Not specified

Drug interactions

Potassium Chloride
Severe
Database

Drug interaction classified as: absorption

Source: DDInter

Potassium Citrate
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Topiramate
Severe
Database

Drug interaction classified as: synergy.

Source: DDInter

Zonisamide
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

8 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.

Related guidelines

Ask House about biperiden

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e, Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team